A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention

Daniel J Feaster, Victoria Mitrani, Myron J. Burns, Brian McCabe, Ahnalee M. Brincks, Allan E Rodriguez, Deshratn Asthana, Michael S. Robbins

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Substance abuse in women with HIV/AIDS overshadows other priorities, including health care. Substance abuse may cause women to avoid health care systems and not adhere to their medication regimen. Methods: A randomized controlled trial tested the efficacy of Structural Ecosystems Therapy (SET) relative to a psychoeducational Health Group (HG) in 126 HIV+ women in recovery. SET, a 4-month intervention, focused on building family support for relapse prevention and HIV medication adherence. Over 12-month follow-up, women were assessed for drug use and medication adherence every 2 months; CD4 T-cell count and HIV viral load were assessed every 4 months. Results: Levels of drug use did not differ by condition. There was a significant difference in curvature of the rates of change in drug use with SET increasing and then decreasing and HG decreasing and then increasing. Women in SET were more likely to increase substance abuse services in response to relapse and separate from drug using household members than were women in HG. These two changes explained the decline in drug use observed within SET between 6 and 12 months. SET showed declines in medication adherence but increases in CD4 T-cell count relative to HG. The increase in CD4 T-cell count in SET was related to increasing proportions of women in SET taking antiretroviral medications. Conclusion: The results of the trial were mixed. Women in SET did not show better drug use or medication adherence outcomes, but did show improvement in CD4 T-cell count and theoretical mechanisms of action on drug relapse.

Original languageEnglish
Pages (from-to)227-234
Number of pages8
JournalDrug and Alcohol Dependence
Volume111
Issue number3
DOIs
StatePublished - Oct 1 2010

Fingerprint

Medication Adherence
Secondary Prevention
Ecosystems
Substance-Related Disorders
Ecosystem
Randomized Controlled Trials
HIV
T-cells
CD4 Lymphocyte Count
Pharmaceutical Preparations
Health
T-Lymphocytes
Therapeutics
Health care
Delivery of Health Care
Recurrence
Women's Health
Viral Load
Acquired Immunodeficiency Syndrome
Recovery

Keywords

  • Family therapy
  • HIV infection
  • Minority women
  • Relapse

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. / Feaster, Daniel J; Mitrani, Victoria; Burns, Myron J.; McCabe, Brian; Brincks, Ahnalee M.; Rodriguez, Allan E; Asthana, Deshratn; Robbins, Michael S.

In: Drug and Alcohol Dependence, Vol. 111, No. 3, 01.10.2010, p. 227-234.

Research output: Contribution to journalArticle

@article{5d4450bf0d55464b9c3245d6201e1eb0,
title = "A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention",
abstract = "Background: Substance abuse in women with HIV/AIDS overshadows other priorities, including health care. Substance abuse may cause women to avoid health care systems and not adhere to their medication regimen. Methods: A randomized controlled trial tested the efficacy of Structural Ecosystems Therapy (SET) relative to a psychoeducational Health Group (HG) in 126 HIV+ women in recovery. SET, a 4-month intervention, focused on building family support for relapse prevention and HIV medication adherence. Over 12-month follow-up, women were assessed for drug use and medication adherence every 2 months; CD4 T-cell count and HIV viral load were assessed every 4 months. Results: Levels of drug use did not differ by condition. There was a significant difference in curvature of the rates of change in drug use with SET increasing and then decreasing and HG decreasing and then increasing. Women in SET were more likely to increase substance abuse services in response to relapse and separate from drug using household members than were women in HG. These two changes explained the decline in drug use observed within SET between 6 and 12 months. SET showed declines in medication adherence but increases in CD4 T-cell count relative to HG. The increase in CD4 T-cell count in SET was related to increasing proportions of women in SET taking antiretroviral medications. Conclusion: The results of the trial were mixed. Women in SET did not show better drug use or medication adherence outcomes, but did show improvement in CD4 T-cell count and theoretical mechanisms of action on drug relapse.",
keywords = "Family therapy, HIV infection, Minority women, Relapse",
author = "Feaster, {Daniel J} and Victoria Mitrani and Burns, {Myron J.} and Brian McCabe and Brincks, {Ahnalee M.} and Rodriguez, {Allan E} and Deshratn Asthana and Robbins, {Michael S.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1016/j.drugalcdep.2010.04.017",
language = "English",
volume = "111",
pages = "227--234",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention

AU - Feaster, Daniel J

AU - Mitrani, Victoria

AU - Burns, Myron J.

AU - McCabe, Brian

AU - Brincks, Ahnalee M.

AU - Rodriguez, Allan E

AU - Asthana, Deshratn

AU - Robbins, Michael S.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Background: Substance abuse in women with HIV/AIDS overshadows other priorities, including health care. Substance abuse may cause women to avoid health care systems and not adhere to their medication regimen. Methods: A randomized controlled trial tested the efficacy of Structural Ecosystems Therapy (SET) relative to a psychoeducational Health Group (HG) in 126 HIV+ women in recovery. SET, a 4-month intervention, focused on building family support for relapse prevention and HIV medication adherence. Over 12-month follow-up, women were assessed for drug use and medication adherence every 2 months; CD4 T-cell count and HIV viral load were assessed every 4 months. Results: Levels of drug use did not differ by condition. There was a significant difference in curvature of the rates of change in drug use with SET increasing and then decreasing and HG decreasing and then increasing. Women in SET were more likely to increase substance abuse services in response to relapse and separate from drug using household members than were women in HG. These two changes explained the decline in drug use observed within SET between 6 and 12 months. SET showed declines in medication adherence but increases in CD4 T-cell count relative to HG. The increase in CD4 T-cell count in SET was related to increasing proportions of women in SET taking antiretroviral medications. Conclusion: The results of the trial were mixed. Women in SET did not show better drug use or medication adherence outcomes, but did show improvement in CD4 T-cell count and theoretical mechanisms of action on drug relapse.

AB - Background: Substance abuse in women with HIV/AIDS overshadows other priorities, including health care. Substance abuse may cause women to avoid health care systems and not adhere to their medication regimen. Methods: A randomized controlled trial tested the efficacy of Structural Ecosystems Therapy (SET) relative to a psychoeducational Health Group (HG) in 126 HIV+ women in recovery. SET, a 4-month intervention, focused on building family support for relapse prevention and HIV medication adherence. Over 12-month follow-up, women were assessed for drug use and medication adherence every 2 months; CD4 T-cell count and HIV viral load were assessed every 4 months. Results: Levels of drug use did not differ by condition. There was a significant difference in curvature of the rates of change in drug use with SET increasing and then decreasing and HG decreasing and then increasing. Women in SET were more likely to increase substance abuse services in response to relapse and separate from drug using household members than were women in HG. These two changes explained the decline in drug use observed within SET between 6 and 12 months. SET showed declines in medication adherence but increases in CD4 T-cell count relative to HG. The increase in CD4 T-cell count in SET was related to increasing proportions of women in SET taking antiretroviral medications. Conclusion: The results of the trial were mixed. Women in SET did not show better drug use or medication adherence outcomes, but did show improvement in CD4 T-cell count and theoretical mechanisms of action on drug relapse.

KW - Family therapy

KW - HIV infection

KW - Minority women

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=77957295353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957295353&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2010.04.017

DO - 10.1016/j.drugalcdep.2010.04.017

M3 - Article

C2 - 20538417

AN - SCOPUS:77957295353

VL - 111

SP - 227

EP - 234

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 3

ER -